The blood products company is still looking like a good buy. The post Morgan Stanley just upgraded their CSL share price ...

Sanofi (SNY) avoids an EU antitrust fine over a disparagement campaign targeting CSL's (CSLLY) flu shot as the EU accepts the ...

Only 50 BMW 3.0 CSLs were built, and each was a collector car before it turned a wheel. That is why car No. 28 matters. Broad ...

Nestled into the pines of southern Wake County is the largest cell-based flu vaccine maker in the world. Why it matters: CSL ...

CSL shares' dramatic recovery from a multi-year low has been a hot topic this year, but there have been a couple of other ...

CSL Canada has expanded public reimbursement for ANDEMBRY® (garadacimab), its once-monthly hereditary angioedema prophylaxis, ...

The Australian pharma company believes the drug will be an important therapeutic option to improve kidney function.

CSL Group, the leading global provider of Critical Connectivity®, has acquired SIMPL Wireless, the US-based IoT eSIM ...

Five analyst houses put the 12-month consensus target for CSL at EUR 113.10 on October 14, 2026, according to Boerse Express.

Nick Heidfeld took 13 F1 podiums without a win. His BMW 3.0 CSL covered 348 km, and a 33 km sister car already made €1,017,500.

CSL Ltd (ASX: CSL) has announced a major new drug development partnership. Does the deal make the healthcare share worth buying?

MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today announced they have entered into an exclusive global collaboration agreement to co-develop ...